Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Olanzapine"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringOlanzapine
brandStringZyprexa (oral, IM acute), Zyprexa Zydis (ODT), Zyprexa Relprevv (LAI), Lybalvi (with samidorphan)
structureFile
classesList of String, delimiter: ,[[:Category:Neuroleptics|Neuroleptic]] [[:Category:Atypical neuroleptics|Atypical neuroleptic (second-generation)]] [[:Category:Thienobenzodiazepines|Thienobenzodiazepine]] [[:Category:Mood stabilizers|Mood stabilizer]]
mechanismString
usesString'"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"', '"`UNIQ--vote-00000023-QINU`"', '"`UNIQ--vote-00000024-QINU`"', '"`UNIQ--vote-00000025-QINU`"'
starting_doseStringSchizophrenia / acute mania: 5-10 mg PO once daily, target 10-15 mg/day. Acute agitation IM: 10 mg, may repeat in 2 hours. Relprevv LAI: 150-300 mg every 4 weeks after oral overlap
preparationsStringTablets 2.5, 5, 7.5, 10, 15, 20 mg; ODT (Zydis) 5, 10, 15, 20 mg; acute IM injection 10 mg/vial; Relprevv LAI 210, 300, 405 mg vials
fda_maxString20 mg/day (oral)
pill_idText
routesList of String, delimiter: ,Oral intramuscular (acute and long-acting)
onsetStringSedation from first dose; neuroleptic effect emerges over days to weeks
durationString24 hours (oral); 2-4 weeks (LAI)
halflifeString21-54 hours'"`UNIQ--ref-00000026-QINU`"'
bioavailabilityString~60% (oral); ~100% (IM)'"`UNIQ--ref-00000027-QINU`"'
pregnancyStringSignal for gestational diabetes and metabolic syndrome with maternal exposure; the metabolic load can be substantial during pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString